Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective tissue—plays a major role ...
Jan 8, 2024
0
83
As we age and gain excess weight, our body's cells undergo stress. This stress is marked by an overproduction of a chemical compound known as ROS (reactive oxygen species), adversely affecting the cells.
Jan 4, 2024
0
33
Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute ...
Dec 14, 2023
0
32
Chronic hepatitis B virus (HBV) infection poses a significant threat to global public health, contributing to liver-related morbidity and mortality. The current diagnostic methods for HBV-related diseases, such as laboratory ...
Sep 28, 2023
0
9
Fatty liver disease is a condition characterized by a build-up of fat in the liver and is the most common chronic liver disease that affects over one billion people. Over time, this can lead to complications including cirrhosis, ...
Sep 18, 2023
0
20
Even vulnerable people, who are at risk of severe COVID-19, achieved good antibody levels after three doses of mRNA vaccine. This is shown by a study from the University of Gothenburg on patients having undergone a bone marrow ...
Aug 1, 2023
0
29
Even low levels of alcohol use can increase the likelihood of developing diseases like cancer and heart disease. A systematic review of studies of the relationship between alcohol use and risk of disease published in Alcohol: ...
Jul 10, 2023
0
21
About 2% of adults worldwide suffer from a condition called non-alcoholic steatohepatitis (Nash), an advanced form of non-alcoholic fatty liver disease. This occurs when fat builds up in the liver, causing inflammation and ...
Jul 3, 2023
0
9
Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis.
Jun 26, 2023
0
102
The UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
Jun 22, 2023
0
1
